XANAX XR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Xanax Xr, and what generic alternatives are available?
Xanax Xr is a drug marketed by Upjohn and is included in one NDA.
The generic ingredient in XANAX XR is alprazolam. There are fifteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Xanax Xr
A generic version of XANAX XR was approved as alprazolam by NOVITIUM PHARMA on October 19th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for XANAX XR?
- What are the global sales for XANAX XR?
- What is Average Wholesale Price for XANAX XR?
Summary for XANAX XR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 53 |
| Patent Applications: | 4,485 |
| Drug Prices: | Drug price information for XANAX XR |
| DailyMed Link: | XANAX XR at DailyMed |
Pharmacology for XANAX XR
| Drug Class | Benzodiazepine |
US Patents and Regulatory Information for XANAX XR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-001 | Jan 17, 2003 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-004 | Jan 17, 2003 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-002 | Jan 17, 2003 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-003 | Jan 17, 2003 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for XANAX XR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-004 | Jan 17, 2003 | ⤷ Sign Up | ⤷ Sign Up |
| Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-001 | Jan 17, 2003 | ⤷ Sign Up | ⤷ Sign Up |
| Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-003 | Jan 17, 2003 | ⤷ Sign Up | ⤷ Sign Up |
| Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-002 | Jan 17, 2003 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
